5 Biotech Stocks to Buy According to Matthew Strobeck’s Birchview Capital
In this article, we discuss 5 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Accelerate Diagnostics Inc (AXDX)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 54,905,000 | $38,255 | -10% | 0% | |
| 2. | 22,235,000 | $15,422 | 1.74% | ||
| 3. | Birchview Capital Matthew Strobeck | 2,252,388 | $3,239 | 2.33% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 452,600 | $652 | +25% | 0% |
| 5. | Millennium Management Israel Englander | 440,480 | $634 | +44% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 20,000 | Director | 30,000 | 2022-01-31 | Filing | |
| $3.94 | 41,912 | Large Shareholder, Director | 18,737,047 | 2022-01-18 | Filing | |
| $3.89 | 31,219 | Large Shareholder, Director | 18,695,135 | 2022-01-14 | Filing | |
| $4.03 | 100,000 | Large Shareholder, Director | 18,663,916 | 2022-01-13 | Filing | |
| $4.34 | 45,226 | Large Shareholder, Director | 18,563,916 | 2022-01-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 29,915 | Officer | 62,493 | 2022-04-28 | Filing | |
| $0.98 | 83,708 | Officer | 208,073 | 2022-04-28 | Filing | |
| $0.98 | 15,072 | Officer | 40,610 | 2022-04-22 | Filing | |
| $3.26 | 3,653 | Officer | 123,385 | 2022-02-01 | Filing | |
| $7.94 | 23,479 | Officer | 112,698 | 2021-06-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 33,566 | $48,335 | 0% | |
| 2. | 5,560,000 | $4,636 | 1.13% | |
| 3. | 3,201 | $4,609 | 0% | |
| 4. | 2,731,856 | $3,934 | 0.77% | |
| 5. | 5,500,000 | $3,606 | 0.05% |
News See All
Hedge Fund and Insider Trading News: Marc Lasry, Archegos Capital Management, ExodusPoint Capital Management, Tucows Inc. (TCX), Savara Inc (SVRA), and More
Why David Einhorn’s value fund posted a large loss in September.
Is AXDX A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Accelerate Diagnostics Inc (AXDX): Hedge Funds Are Snapping Up
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is Accelerate Diagnostics Inc (AXDX) Going to Burn These Hedge Funds?
Is Accelerate Diagnostics Inc (NASDAQ:AXDX) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on...
Is Accelerate Diagnostics Inc (AXDX) Going To Burn These Hedge Funds ?
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Did Hedge Funds Drop The Ball On Accelerate Diagnostics Inc (AXDX) ?
"Market volatility has picked up again over the past few weeks. Headlines highlight risks regarding interest rates, the Fed, China, house prices, auto sales, trade wars, and more. Uncertainty abounds.
Hedge Fund and Insider Trading News: Bill Ackman, David Tepper, Accelerate Diagnostics, Inc. (AXDX), Vanguard Natural Resources Inc (VNRR), CalAmp Corp. (CAMP), and More
Pershing Square Capital Management is one of the world’s largest publicly traded hedge funds, whose founder and chief executive, Bill Ackman needs no introduction.
Is Accelerate Diagnostics Inc (AXDX) a Good Stock to Buy?
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...
Birchview Capital’s Top Healthcare Stock Picks
Birchview Capital is a Vermont-based biosciences-focused long/short equity hedge fund founded by Dr. Matthew Strobeck in 2014. Dr. Strobeck holds a Ph.D.
Billionaire Hedge Funds
